e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo
Pujols L., Benitez P., Alobid I., Martinez-Anton A., Roca-Ferrer J., Mullol J., Picado C.
Source:
Eur Respir J 2009; 33: 502-508
Journal Issue:
March
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pujols L., Benitez P., Alobid I., Martinez-Anton A., Roca-Ferrer J., Mullol J., Picado C.. Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo. Eur Respir J 2009; 33: 502-508
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Cox-2 regulation by IL-1β through MAPKs: A comparison of nasal mucosa and nasal polyps fibroblasts from AIA patients
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Increased COX-1 and COX-2 mRNA expression and prostaglandin E2 production by dendritic cells from patients with asthma
Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production
Year: 2003
Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps
Source: Eur Respir J 2004; 24 : 594-600
Year: 2004
Anti-proliferative and anti-inflammatory effect of glucocorticoids in nasal mucosa and nasal polyp fibroblasts
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Regulation of E-cadherin expression by dexamethasone and tumour necrosis factor-α in nasal epithelium
Source: Eur Respir J 2002; 20: 1430-1436
Year: 2002
NOTCH-1 activation sustains hyperexpression of IL-33 in the epithelium of nasal polyps
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
IL-13 induces glucocorticoid resistance in iNOS expression and activity in human airway epithelial cells (HAECs)
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Increased expression of IL-19 in metaplastic epithelium of patients with chronic rhinosinusitis and nasal polyps
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Source: Eur Respir J 2012; 39: 439-445
Year: 2012
Effects of TNF-alpha on the human nasal mucosa
in vivo
Source: Eur Respir J 2006; 28: Suppl. 50, 672s
Year: 2006
Role of IL-13Ra2 in modulating IL-13 induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019
Chemokine expression, apoptosis, and proliferation in the airway mucosa at steroid-mediated resolution of allergic rhinitis
Source: Eur Respir J 2003; 22: Suppl. 45, 32s
Year: 2003
Inducible NOS overexpression is related to lymphocyte-driven inflammation in bronchial mucosa of smokers
Source: Eur Respir J 2003; 22: Suppl. 45, 549s
Year: 2003
Glucocorticoids and indacaterol regulated gene expressions profiling in human bronchial epithelial cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012
Lipopolysacharide modulates glucocorticoid receptor function in nasal mucosa and polyp fibroblasts
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Bronchial thermoplasty may increase steroid sensitivity by upregulating the expression of the glucocorticoid receptor
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
Metformin regulates sirtuin expression in airway epithelial cells
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Differential expression of mRNA encoding for pro-inflammatory and angiogenic proteins in aspirin-tolerant and -intolerant asthma, following oral provocative aspirin challenge
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept